Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells

Journal of Endocrinology

Volumn 185, Issue 3, 2005, Pages 577-592

  Gilad, Liat Abovich ^a   Bresler, Tali ^a   Gnainsky, Julia ^a   Smirnoff, Patricia ^a   Schwartz, Betty ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA CYCLODEXTRIN DERIVATIVE; CHOLESTEROL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; RAF PROTEIN; RAS PROTEIN; SULINDAC SULFIDE; SURAMIN; VITAMIN D RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN HT29; CELL STRAIN MCF 7; COLON CANCER; CONTROLLED STUDY; CYTOSOL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CAVEOLAE; CELL LINE, TUMOR; CELL MEMBRANE; COLONIC NEOPLASMS; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 21244483493     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05770     Document Type: Article

References (75)

1. Arai H, Miyamoto K & Taketani Y 1997 A vitamin D receptor gene polymorphism in the translational initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. Journal of Bone and Mineral Research 12 915-921.
2. Arai N, Strom A, Rafter JJ & Gustafsson JA 2000 Estrogen receptor β mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochemical and Biophysical Research Communications 270 425-431.
3. Aronica SM, Kraus WL & Katznellenbogen BS 1994 Estrogen action via cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. PNAS 91 8517-8521.
4. 47Ca absorption in postmenopausal osteoporosis. Journal of Clinical Investigation 44 1960-1967.
5. Berthois Y, Pourreau-Schneider N, Gaudilhon P, Mittre H, Tubiana N & Martin PM 1986 Estradiol membrane binding sites on human breast cancer cell lines. Use of fluorescent estradiol conjugate to demonstrate plasma membrane binding systems. Journal of Steroid Biochemistry 25 963-972.
6. Blackmore PF, Neulen J, Lattanzio F & Beebe SJ 1991 Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. Journal of Biological Chemistry 266 18655-18659.
7. Bullamore JR, Gallagher JC, Wilkinson R, Nordin BEC & Marshall DH 1970 Effect of age on calcium absorption. Lancet 2 535-537.
8. Byrne MI, Flanagan L, Tenniswood MPR & Welsh J 2000 Identification of a hormone- responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene. Endocrinology 141 2829-2836.
9. Campbell-Thompson M, Lynch IJ & Bhardwa B 2001 Expression of estrogen receptor (ER) subtypes and ERβ isoforms in colon cancer. Cancer Research 61 632-640.
10. Chaban VV, Lakhter JA & Micevych P 2004 A membrane estrogen receptor mediates intracellular calcium in astrocytes. Endocrinology 149 1-23.
11. Chang WJ, Ying Y, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, Mumby SM, Gilman AG & Anderson RG 1994 Purification and characterization of smooth muscle cell caveolae. Journal of Cell Biology 126 127-138.
12. Civitelli R, Agnusdei D, Nardi P, Zacchei F, Avioli LV & Gennari C 1988 Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis. Calcified Tissue International 42 77-86.
13. Couet J, Li S, Okamoto T, Ikezu T & Lisanti MP 1997 Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. Journal of Biological Chemistry 272 6525-6533.
14. Csikos T, Chung O & Unger T 1998 Receptors and their classification: focus on angiotensin II and the AT2 receptor. Journal of Human Hypertension 12 311-318.
15. Cullen R, McGuire T, Diggin P, Hill A, McDermott E, O'Higgins N & Duffy MJ 2000 Detection of estrogen receptor beta mRNA in breast cancer using RT-PCR. International Journal of Biological Markers 15 114-115.
16. Dokoh S, Donaldson CA & Haussler MR 1984 Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptors. Cancer Research 44 2103-2109.
17. Duncan WE, Glass AR & Wray HL 1991 Estrogen regulation of the nuclear 1,25-dihydroxyvitamin D3 receptor in rat liver and kidney. Endocrinology 129 2318-2324.
18. Endoh H, Sasaki H, Maruyama K, Takeyama KI, Waga I, Shimizu T, Kato S & Kawashima H 1997 Rapid activation of MAP kinase by estrogen in bone cell line. Biochemical and Biophysical Research Communications 235 99-102.
19. Escaleira MT, Sonohara S & Brentani MM 1993 Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in T 47D breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 45 257-263.
20. Fielding CJ & Fielding PE 2000 Cholesterol and caveolae: structural and functional relationships. Biochimica et Biophysica Acta 1529 210-222.
21. Fiorelli G, Picariello L, Martineti V, Tonelli F & Brandi LM 1999 Functional estrogen receptor β in colon cancer cells. Biochemical and Biophysical Research Communication 261 521-527.
22. Flores-Delgado G, Bringas P, Buckley S, Anderson KD & Warburton D 2001 Nongenomic estrogen action in human lung myofibroblasts. Biochemical and Biophysical Research Communications 283 661-667.
23. Francavilla A, Di Leo A, Polimeno L, Conte D, Barone M, Fanizza G, Chiumarulo C, Rizzo G & Rubino M 1987 Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 93 1301-1306.
24. Francis RM, Peacock M, Storer JH & Nordin BEC 1984 Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D on the bowel. Clinical Science 66 103-107.
25. Fujiuchi S, Ohsaki Y & Kikuchi K 1997 Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor. Oncology 54 134-140.
26. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Amoud SB & Deluca HF 1979 Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. Journal of Clinical Investigation 64 729-736.
27. Gennari C, Agnusdei D, Nardi P & Civitelli R 1990 Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in overectomized women. Journal of Clinical Endocrinology and Metabolism 71 1288-1293.
28. Glass CK, Rose DW & Rosenfeld MG 1997 Nuclear receptor coactivators. Current Opinion in Cell Biology 9 222-232.
29. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R & Feldman D 1996 The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. Journal of Bone and Mineral Research 11 1850-1855.
30. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C & Brown M 1994 Estrogen receptor associated proteins: possible mediators of hormone-induced transcription. Science 264 1455-t458.
31. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B & Feldman D 1997 The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. Journal of Bone and Mineral Research 12 1043-1048.
32. Heaney RP, Recker RR & Saville PD 1978 Menopausal changes in calcium balance performance. Journal of Laboratory and Clinical Medicine 92 953-963.
33. Hendrickse CW, Jones CE, Donovan IA, Neoptolemos JP & Baker PR 1993 Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. British Journal of Surgery 80 636-640.
34. Herrmann C, Block C, Geisen C, Haas K, Weber C, Winde G, Moroy T & Muller O 1998 Sulindac inhibits Ras signaling. Oncogene 17 1769-1776.
35. Horst RL, Goff JP & Reinhardt TA 1990 Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor. Endocrinology 126 1053-1057.
36. Jehan F & DeLuca HF 1997 Cloning and characterization of the mouse vitamin D receptor promoter. PNAS 94 10138-10143.
37. LaPushin R, Totpal K, Higuchi M & Aggarwal BB 1994 Suramin inhibits tumor cell cytotoxicity mediated through natural killer cells, lymphokine-activated killer cells, monocytes, and tumor necrosis factor. Journal of Clinical Immunology 14 39-49.
38. Leland P, Obiri N, Aggarwal BB & Puri RK 1995 Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response. Oncology Research 7 227-235.
39. Le Mellay V, Grosse B & Lieberherr M 1997 Phospholipase C beta and membrane action of calcitriol and estradiol. Journal of Biological Chemistry 272 11902-11907.
40. Levy J, Zuili I, Yankowitz N & Shany S 1984 Induction of cytosolic receptors for 1α,25-dihydroxyvitamin D3 in the immature rat uterus by oestradiol. Journal of Endocrinology 100 265-269.
41. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I & Lisanti MP 1995 Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin. Journal of Biological Chemistry 270 15693-15701.
42. Liel Y, Kraus S, Levy J & Shany S 1992 Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D3 receptors in osteoblast-like cells (ROS 17/2.8). Endocrinology 130 2597-2601.
43. Liel Y, Shany S, Smirnoff P & Schwartz B 1999 Estrogen increases 1,25-dihydroxyvitamin receptor expression and bioresponse in the rat duodenal mucosa. Endocrinology 140 280-285.
44. Luqmani YA, Ryall G, Shousha S, Coombes RC 1992 An immunohistochemical survey of pS2 expression in human epithelial cancers. International Journal of Cancer 50 302-304
45. Meggouh F, Lointier P & Saez S 1991 Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Research 51 1227-1233.
46. ras /MAPK-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO Journal 15 1292-1300.
47. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Bottero D, Varricchio L, Nanayakkara M, Rotondi A & Auricchio F 2003 Sex steroid hormones act as growth factors. Journal of Steroid Biochemistry and Molecular Biology 83 31-35
48. Mineo C, James GL, Smart EJ & Anderson RG 1996 Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. Journal of Biological Chemistry 271 11930-11935.
49. Monje P, Marinissen MJ & Gutkind JS 2003 Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Molecular and Cellular Biology 23 7030-7043.
50. Nahmias C & Strosberg AD 1995 The angiotensin AT2 receptor: searching for signal-transduction and physiological function. Trends in Pharmacological Sciences 16 223-225.
51. Nemere I, Dormanen MC, Hammond MW, Okamua WH & Norman AW 1994 Identification of specific binding pro-branes of chick intestinal epithelium and relationship to transcaltachia. Journal of Biological Chemistry 269 23750-23756.
52. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M & Gustafsson JA 2001 Mechanisms of estrogen action. Physiological Reviews 81 1535-1565.
53. Norman AW, Mizwicki MT & Norman DP 2004 Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nature Reviews. Drug Discovery 3 27-41.
54. Paech K, Webb P, Kuiper GJ, Nilsson S, Gustafsson JA, Kushner PJ & Scanlan TS 1997 Differential ligand activtion of estrogen receptors ERα and ERβ at AP1 sites. Science 277 1508-1510.
55. Pappas TC, Gametchu B & Wason CS 1995 Membrane estrogen receptors identified by multiple antibody labeling and impeded ligand binding. FASEB Journal 9 404-410.
56. Pettersson K, Grandien K, Kuiper GJ & Gustafsson JA 1997 Mouse estrogen receptor β forms estrogen response element binding heterodimers with estrogen receptor α. Molecular Endocrinology 11 1486-1496.
57. Pfahl M 1993 Nuclear receptor/AP1 interaction. Endocrine Reviews 14 651-658.
58. Pietras R & Szego CM 1977 Specific binding sites for oestrogen at outer surfaces of isolated endometrial cells. Nature 265 69-72.
59. Pietras RJ & Szego CM 1980 Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochemical Journal 191 743-760.
60. Qi X, Pramanik R, Wang J, Schultz RM, Maitra RK, Han J, DeLuca HF & Chen G 2002 Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Journal of Biological Chemistry 277 25884-25892.
61. Robbins SM, Quintrell NA & Bishop MJ 1995 Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae. Molecular and Cellular Biology 15 3507-3515.
62. Russell JE, Morimoto S, Brige SJ, Fausto A & Avioli LV 1986 Effects of age and estrogen on calcium absorption in the rat. Journal of Bone and Mineral Research 1 185-189.
63. Schwartz B, Smirnoff P, Shany S & Liel Y 2000 Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Molecular and Cellular Biochemistry 203 87-93.
64. Smart EJ, Ying YS, Mineo C & Anderson RG 1995 A detergent-free method for purifying caveolae membrane from tissue culture cells PNAS 92 10104-10108.
65. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M & Lisanti MP 1995 Co-purification and Direct Interaction of Ras with Caveolin, an Integral Membrane Protein of Caveolae Microdomains Detergent-free purification of caveolae membranes. Journal of Biological Chemistry 271 9690-9697.
66. Tada H, Shiho O, Kuroshima KI, Koyama M & Tsukamoto K 1986 An improved colorimetric assay for interleukin 2. Journal of Immunological Methods 93 157-167.
67. Takamoto S, Seino Y, Sacktor B & Liang CT 1990 Effect of age on 1,25-dihydroxyvitamin D3 receptors in Wistar rats. Biochimica et Biophysica Acta 1034 22-28.
68. Takeda H, Yamakawa M, Takahashi T, Imai Y & Ishikawa M 1992 An immunohistochemical study with an estrogen receptor-related protein (ER-D5) in human colorectal cancer. Cancer 69 907-912.
69. Tesarik J & Menoza C 1995 Nongenomic effects of 17 beta estradiol on maturing human oocytes: relationship to oocyte developmental potential. Journal of Clinical Endocrinology and Metabolism 80 1433-1438.
70. Theisinger B, Guthke R, Blin N, Welter C & Seitz G 1993 Influence of steroid hormones on pS2/BCEI gene expression in xenografted colon tumors. In Vivo 7 411-414.
71. Vincent TS, Hazen-Martin DJ & Garvin AJ 1996 Inhibition of insulin-like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo. Cancer Letters 103 49-56.
72. Walters MR 1981 An estrogen-stimulated 1,25-dihydroxyvitamin D3 receptor in rat uterus. Biochemical and Biophysical Research Communications 103 721-726.
73. Watters JJ, Campbell JS, Cunningham MJ, Krebs GE & Dorsa DM 1997 Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138 4030-4033.
74. Wehling M 1995 Nongenomic aldosterone affects the cell membrane as a specific target of mineralocorticoid action. Steroids 60 153-156.
75. Welter C, Theisinger B, Rio MC, Seitz G, Schuder G & Blin N 1994 Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumors. International Journal of Cancer 56 52-55.